JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
JVI Accepts, published online ahead of print on 23 January 2008
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JVI.01700-07v1
82/7/3438    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Neumann-Haefelin, C.
Right arrow Articles by Timm, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Neumann-Haefelin, C.
Right arrow Articles by Timm, J.

 Previous Article  |  Next Article 

J. Virol. doi:10.1128/JVI.01700-07
Copyright (c) 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Analysis of the evolutionary forces in an immunodominant CD8 epitope in the hepatitis C virus at a population level

Christoph Neumann-Haefelin, David N. Frick, Jing Jing Wang, Oliver G. Pybus, Shadi Salloum, Gagandeep S. Narula, Anna Eckart, Andrea Biezynski, Thomas Eiermann, Paul Klenerman, Sergei Viazov, Michael Roggendorf, Robert Thimme, Markus Reiser, and Jörg Timm*

Department of Medicine II, University of Freiburg, Hugstetter Str. 55, 79106 Freiburg, Germany; Department of Biochemistry & Molecular Biology, New York Medical College, Valhalla, USA; Department of Virology, University of Essen, Hufelandstr. 55, 45122 Essen, Germany; Department of Zoology, University of Oxford, South Parks Road, Oxford, OX1 3PS, UK; Department of Transfusion Medicine, University of Hamburg, Martinistr. 52, 20246 Hamburg, Germany; Nuffield Department of Medicine, South Parks Road, Oxford OX1 3SY, UK; Paracelsus Hospital Marl, Department of Medicine, Lipper Weg 11, 45770 Marl, Germany

* To whom correspondence should be addressed. Email: joerg.timm{at}uni-due.de.


   Abstract

Failure of the adaptive immune response to control infection with the hepatitis C virus can result from mutational escape in targeted T cell epitopes. Recent studies suggest that T cell immune pressure is an important factor in the evolution of the non-structural proteins in HCV. The aim of this study was to characterize the forces that contribute to viral evolution in an HLA-A*01 restricted epitope in HCV NS3. This epitope represents a potentially attractive target for vaccination strategies as it is conserved across all genotypes. In our cohort of subjects with chronic HCV infection (genotype 1b or 3a) it is a frequently recognized CD8 epitope in HLA-A*01 positive subjects. Viral sequence data reveal that an escape variant is the dominant residue in both genotypes. The predominant Y1444F substitution seemingly impairs binding to the HLA-A*01 molecule, which may have an important impact on the ability to prime a functional CD8 response upon infection. Interestingly, a case of evolution towards the prototype sequence was observed during chronic infection, possibly because the helicase activity of the protein containing the Y1444F substitution is reduced compared to the prototype sequence. Comparison of HCV sequences from Asia and Europe suggests that the frequency of the HLA-A*01 allele in a population may influence the frequency of the escape variant in circulating strains. These data suggest a complex interaction of multiple forces shaping the evolution of HCV in which immune pressure both within the individual but also at the population level in addition to functional constraints are important contributing factors.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. Mol. Cell. Biol. Microbiol. Mol. Biol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2008 by the American Society for Microbiology. All rights reserved.